Press Releases

Based on VOLGA Phase III trial results which demonstrated statistically significant and clinically meaningful improvements in event-free survival and overall survival AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) in combination with enfortumab vedotin (EV) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or have declined cisplatin-based chemotherapy. The Food and Drug Administration (FDA) grants Priority Review to applications for medicines that, if approved, would offer significant improvements over available treatment options by demonstrati

Marygold Stockholders to Receive $2.00 Per Share in Cash, a 100% Premium to the Unaffected Share Price Transaction to Provide Capital Investment in USCF, a Wholly-Owned Subsidiary of Marygold, to Support Continued Growth and Product Excellence Incoming CEO of Marygold, Tim Rotolo, to Partner with MDP and USCF Leadership to Scale ETF Platform Madison Dearborn Partners ("MDP" or "the Firm"), a leading private equity investment firm based in Chicago, today announced that funds managed by MDP have entered into a definitive agreement to acquire all of the outstanding shares of The Marygold Companies, Inc. (NYSE:MGLD) ("Marygold" or "the Company"), a global holding firm specializing in fina

Atlas Energy Solutions Inc. (NYSE:AESI) ("Atlas") today announced that two wholly owned, indirect subsidiaries of Atlas have executed separate cost reimbursement agreements with a leading frontier AI lab in conjunction with the execution of equipment purchase agreements to secure long-lead-time supporting equipment and incremental power generation equipment for specific data center projects. The cost reimbursement agreements allocate the related equipment to this specific customer and facilitate near-term financing. The first cost reimbursement agreement supports the purchase of balance-of-plant equipment, including emissions control systems, electrical distribution equipment, battery ene

Five-year overall survival rate was 69.2%, adding to growing long-term evidence supporting the curative potential of CARVYKTI in earlier-line RRMM BRIDGEWATER, N.J., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ:LEGN) (Legend Biotech), a global leader in cell therapy, today announced five-year follow-up data from CARTITUDE-2 Cohort A (n=20) evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) in patients with relapsed/refractory multiple myeloma (RRMM) after one to three prior lines of therapy after a median follow-up of 60.7 months. These data were presented today at the 2026 International Myeloma Society (IMS) Annual Meeting in Glasgow, Scotland (Abstract

Vince Holding Corp., (NASDAQ:VNCE) ("VNCE" or the "Company"), a global retail platform, today announced that the Company is scheduled to participate in a fireside chat at the Noble Capital Markets Emerging Growth Virtual Equity Conference on Friday, October 2, 2026, at 2:30 PM Eastern Time. A webcast of the presentation will be available in the "Investors" section of the Company’s website at http://investors.vince.com. The webcast will be archived and available on the website shortly after the event. ABOUT VINCE HOLDING CORP. Vince Holding Corp. is a global retail platform that operates the Vince brand women's and men's ready to wear business and the October’s Very Own ("OVO") brand a

Data center executive brings more than two decades of customer relationship experience Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation ("HDC"), today announced that Jay Elms has joined the Company’s executive team as Chief Commercial Officer. In this role, Elms will be responsible for growing customer relationships and overseeing the customer experience from initial engagement through deployment. "We are excited to welcome Jay to our executive team," said Adam Sullivan, Chief Executive Officer of Core Scientific. "Jay joins Core Scientific at an important moment as we enter our next phase of growt

Immunomodulatory Effects of Cemsidomide with Dexamethasone from Phase 1 Trial Demonstrated Robust T-cell Activation, a Key Component of Cemsidomide’s Dual Mechanism of Action Biomarker Data from First Two Patients in Phase 1b Trial of Cemsidomide with Elranatamab Reinforce Cemsidomide’s Ability to Drive T-cell Expansion and Activation, and Prevent T-cell Exhaustion When Combined with Immune-based Therapies First Cemsidomide Dose Level (75 µg) in Phase 1b Trial with Elranatamab Declared Safe by Safety Data Review Committee; Advancing Trial to Dose Expansion and Escalation Cohorts with Data from All Cohorts Evaluated Expected in Mid-2027 WATERTOWN, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -

Partnership Combines Reborn Coffee’s Brand and Roasting Platform with Visvita’s U.S. and Mexican Distribution Infrastructure to Scale Franchise Supply and Launch Co-Branded RTD Lineup BREA, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (NASDAQ:REBN) (the "Company"), a leading innovator in specialty coffee, today announced that it has entered into a strategic Memorandum of Understanding (the "MOU") with Visvita, a beverage and distribution company with established supplier relationships and logistics infrastructure spanning retail channels in the United States and Mexico. The MOU establishes a framework to combine Reborn Coffee’s brand and roasting platform with Visvita’s

NORWALK, Conn., Sept. 25, 2026 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS, NASDAQ:FDS), a leading global intelligence and AI solutions provider to the financial markets, today announced the appointment of Marcel Prins to its Board of Directors. Prins brings over 25 years of experience spanning operations, technology, and asset management. From 2022-2026, he served as Chief Operating Officer and a director of Robeco, a global asset manager based in the Netherlands.   During his tenure, he drove innovation and accelerated Robeco’s digital transformation, including defining and executing a multi-year technology strategy, introducing a modern data platform, strengthening data governance, and incre

$15.0 Million Award to Support Advancement of RECLAIM-LN, a Phase 2 Potentially Registrational Trial of FT819 Off-the-Shelf CAR T-Cell Therapy in Lupus Nephritis CLIN2 Grant is a highly competitive award from CIRM to fund advancing clinical trials for stem cell and gene therapies that have the potential to provide transformative benefits to patients and the healthcare system SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that

Marine Security Project to Be the First Tenant, Advancing the Company's Advanced Manufacturing Strategy in the UAEUMM AL QUWAIN, UAE, Sept. 25, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ:AIIO) ("Robo.ai" or the "Company") today announced that a groundbreaking ceremony was held in Umm Al Quwain for Phase I of the ALIF Holding Group Industrial Park (the "Industrial Park"). The first of the Industrial Park's three planned phases will have a designed gross floor area of approximately 8,845 square meters and is expected to involve the refurbishment of existing factory premises to provide local integration and manufacturing capabilities for ALIF Holding's industrial projects. The site is intended t

Intelligent power management company Eaton (NYSE:ETN) today announced it has signed an agreement to acquire COL Group from Oaktree’s Power Opportunities strategy. COL Group is a leader in medium-voltage electrical distribution solutions, including SF₆-free switchgear, grid automation technologies and modular power systems. The acquisition will expand Eaton's European power distribution capabilities and manufacturing footprint, enhancing its ability to support growing customer demand across data center and utility markets. "COL Group brings complementary technologies, manufacturing capabilities and engineering expertise that will further strengthen Eaton's European power distribution platf

Approval extends VEON's digital financial services ambitions under its "Invest in Bangladesh NOW!" framework Dubai, Dhaka and New York, September 25, 2026 – VEON Ltd. (NASDAQ:VEON, ", VEON", )), a global digital operator, today announced that a joint venture between VEON Digital Financial Group and Square Group, one of Bangladesh's leading business conglomerates, has received approval for a Digital Bank license from Bangladesh Bank, the central bank of Bangladesh. The license marks VEON's entry into full-scale digital banking in Bangladesh, building on Banglalink's existing Payment Service Provider (PSP) license, which underpins its Mukto Pay digital payments service. This milestone reflec

CHARLOTTE, N.C., Sept. 25, 2026 /PRNewswire/ -- Duke Energy's board of directors today announced the appointment of Joyce Mullen as a new board member, effective Sept. 28. Mullen will serve on the Audit Committee and the Operations and Nuclear Oversight Committee. Mullen retired as president and CEO of Insight Enterprises in April 2026. She continues to advise its leadership as executive vice president of strategic development."As we serve our customers across a vibrant operating territory that is growing every day, Joyce's experience as a transformative leader will help us further accelerate how we shape the future of energy,"

SHANGHAI, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today published a circular (the "EGM Circular") to provide shareholders with information on the proposals that will be put forward at the Company’s upcoming extraordinary general meeting of the shareholders (the "EGM") for shareholders’ approval and a notice of the EGM (the "EGM Notice"). The EGM will be held at Building 3, Guozheng Center, No. 485 Zhengli Road, Yangpu District, Shanghai, People’s Republic of China, on October 28, 2026 at 4:30 p.m. (Beijing time). The EGM Circular, the EGM Notice and the form o

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on September 24, 2026, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options to purchase an aggregate of 94,000 shares of the Company's common stock to three newly hired employees. The stock options were granted under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan (2023 Inducement Plan) as an inducement material to such individuals' entering into employment with IDEAYA in accordance with Nasdaq Lis

BEIJING, Sept. 25, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) ("Yiren Digital" or the "Company"), a leading company specializing in financial technology and artificial intelligence innovation across multiple industries in China and global markets, today announced that it plans to release its unaudited financial results for the second quarter ended June 30, 2026 before U.S. market opens on Wednesday, September 30, 2026. Yiren Digital's management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on September 30, 2026 (or 8:00 p.m. Beijing/Hong Kong Time on September 30, 2026).Participants who wish to join the call should register online in advance of the conference

AngloGold Ashanti plc ("AngloGold Ashanti", "AGA", or the "Company") (NYSE:AU, JSE: ANG)) is today hosting a site visit for institutional investors and analysts across its consolidated Beatty Mining District in southern Nevada. The visit provides on update on the Company’s progress toward developing the newest major gold-producing district in the US, anchored first by the North Bullfrog Project and then the Tier-One Arthur Gold Project as the region’s cornerstone.1 The presentation pack is available for download on the AngloGold Ashanti website at www.anglogoldashanti.com. Endnotes A Tier One asset is generally defined by AngloGold Ashanti as a large, long-life, low-cost operation

New facility delivers a key 2026 milestone and advances Vertical’s transition from prototype development towards aircraft manufacturing Centre will assemble certification-conforming Valo aircraft and hybrid-electric demonstrator ahead of production of initial customer deliveries Facility is designed to assemble more than 25 Valo aircraft annually during early production Plans for a separate full-scale production site, intended to support higher-volume manufacturing, to be announced later this year Vertical Aerospace ("Vertical" or the "Company") (NYSE:EVTL), a global aerospace and technology company pioneering electric aviation, today announced the opening of a dedicated Aircra

AngloGold Ashanti plc (the "Company") (NYSE:AU, JSE: ANG)) is pleased to announce the appointment of Paul Graves as an independent non-executive director of the Company with effect from 1 October 2026. Mr. Graves will serve as a member of the Audit and Risk Committee and the Social, Ethics and Sustainability Committee. Mr. Graves has over 30 years of experience in global natural resources, finance, and public company leadership. Most recently, he served as Chief Executive of Rio Tinto Lithium, following Rio Tinto's acquisition of Arcadium Lithium, where he was President and CEO. He previously led Livent Corporation as President and CEO and served as Executive Vice President and Chief Fina